Bouve College

Nov 9, 2024 | jclinepi.com | Bouve College

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Jul 24, 2024 | academic.oup.com | Bouve College

The National Institutes of Health’s All of Us Research Program addresses gaps in biomedical research by collecting health data from diverse populations. Pregnant individuals have historically been underrepresented in biomedical research, and pregnancy-related research is often limited by data availability, sample size, and inadequate representation of the diversity of pregnant people.

Jul 24, 2024 | academic.oup.com | Bouve College

Despite easy-to-use tools like the Cohort Builder, using All of Us Research Program data for complex research questions requires a relatively high level of technical expertise. We aimed to increase research and training capacity and reduce barriers to entry for the All of Us community through an R package, allofus.

Jun 17, 2024 | bmcmedicine.biomedcentral.com | Sun Yat-sen |Bouve College

This systematic review and meta-analysis adhered to the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, as detailed in Additional file 1: Table S1. The methodology employed in this review was guided by the Cochrane Handbook for Systematic Reviews of Interventions. This study was registered with PROSPERO (registration number: 321343). The protocol can be accessed at https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=321343.

Apr 23, 2024 | link.springer.com | Bouve College

AbstractAlthough many recent advancements have been made in women’s health, perhaps one of the most neglected areas of research is the diagnosis and treatment of high-grade endometrial cancer (EnCa). The molecular classification of EnCa in concert with histology was a major step forward. The integration of profiling for mismatch repair deficiency and Human Epidermal Growth Factor 2 (HER2) overexpression, can further inform treatment options, especially for drug resistant recurrent disease.